BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37816756)

  • 21. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
    Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
    Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.
    Bonen A
    Eur J Appl Physiol; 2001 Nov; 86(1):6-11. PubMed ID: 11820324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
    Singh M; Afonso J; Sharma D; Gupta R; Kumar V; Rani R; Baltazar F; Kumar V
    Semin Cancer Biol; 2023 May; 90():1-14. PubMed ID: 36706846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.
    Sanità P; Capulli M; Teti A; Galatioto GP; Vicentini C; Chiarugi P; Bologna M; Angelucci A
    BMC Cancer; 2014 Mar; 14():154. PubMed ID: 24597899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
    Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
    Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocarboxylate transporters 1 and 4: expression and regulation by PPARα in ovine ruminal epithelial cells.
    Benesch F; Dengler F; Masur F; Pfannkuche H; Gäbel G
    Am J Physiol Regul Integr Comp Physiol; 2014 Dec; 307(12):R1428-37. PubMed ID: 25320343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
    Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
    Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack.
    Fang Y; Liu W; Tang Z; Ji X; Zhou Y; Song S; Tian M; Tao C; Huang R; Zhu G; Jiang X; Gao J; Qu W; Wang H; Zhou P; Wu X; Jin L; Sun H; Ding Z; Peng Y; Zhao S; Zhou J; Fan J; Xu W; Shi Y
    Hepatology; 2023 Jan; 77(1):109-123. PubMed ID: 35043976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis.
    Yuan C; Zhang J; Lou J; Wang S; Jiang Y; Wu F; Wang S
    Bioengineered; 2021 Dec; 12(1):3850-3863. PubMed ID: 34269158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.
    Fiaschi T; Marini A; Giannoni E; Taddei ML; Gandellini P; De Donatis A; Lanciotti M; Serni S; Cirri P; Chiarugi P
    Cancer Res; 2012 Oct; 72(19):5130-40. PubMed ID: 22850421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status.
    Granja S; Marchiq I; Le Floch R; Moura CS; Baltazar F; Pouysségur J
    Oncotarget; 2015 Mar; 6(9):6708-21. PubMed ID: 25894929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.
    Ullah MS; Davies AJ; Halestrap AP
    J Biol Chem; 2006 Apr; 281(14):9030-7. PubMed ID: 16452478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer.
    Choi SY; Xue H; Wu R; Fazli L; Lin D; Collins CC; Gleave ME; Gout PW; Wang Y
    Clin Cancer Res; 2016 Jun; 22(11):2721-33. PubMed ID: 26755530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical evaluation and prognostic value of monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in T-cell non-Hodgkin lymphoma.
    Zhao H; Chen Y; Liao YP; Chen HM; Yang QH; Xiao Y; Luo J; Chen ZZ; Yi L; Hu GY
    Clin Exp Med; 2023 Feb; 23(1):55-64. PubMed ID: 35239073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of Astrocytic Monocarboxylate Transporter 4 in the Motor Cortex Leads to Loss of Dendritic Spines and a Deficit in Motor Learning.
    Lundquist AJ; Llewellyn GN; Kishi SH; Jakowec NA; Cannon PM; Petzinger GM; Jakowec MW
    Mol Neurobiol; 2022 Feb; 59(2):1002-1017. PubMed ID: 34822124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes.
    Pérez de Heredia F; Wood IS; Trayhurn P
    Pflugers Arch; 2010 Feb; 459(3):509-18. PubMed ID: 19876643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export.
    Li J; Wu Z; Chen G; Wang X; Zhu X; Zhang Y; Zhang R; Wu W; Zhu Y; Ma L; Yu H
    Phytomedicine; 2023 Jan; 109():154618. PubMed ID: 36610137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Holistic Evolutionary and 3D Pharmacophore Modelling Study Provides Insights into the Metabolism, Function, and Substrate Selectivity of the Human Monocarboxylate Transporter 4 (hMCT4).
    Papakonstantinou E; Vlachakis D; Thireou T; Vlachoyiannopoulos PG; Eliopoulos E
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.
    Long Y; Gao Z; Hu X; Xiang F; Wu Z; Zhang J; Han X; Yin L; Qin J; Lan L; Yin F; Wang Y
    Cancer Med; 2018 Sep; 7(9):4690-4700. PubMed ID: 30051648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.